Zydus Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

100.60

101.20

102.40

102.40

102.40

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

15,615.90

13,538.20

13,138.10

12,642.10

11,157.80

Loan funds

Secured loans

6,173.50

4,822.50

2,662.60

3,915.90

2,954.40

Unsecured loans

-

-

-

-

-

Total

21,890.00

18,461.90

15,903.10

16,660.40

14,214.60

Uses of funds

Fixed assets

Gross block

8,509.00

7,849.20

7,550.90

6,894.20

6,471.40

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

4,139.60

3,665.10

3,215.00

2,782.20

2,362.40

Net block

4,369.40

4,184.10

4,335.90

4,112.00

4,109.00

Capital work-in-progress

633.90

739.30

384.00

570.50

552.60

Investments

7,283.00

4,879.30

5,118.00

6,470.60

6,404.10

Net current assets

Current assets, loans & advances

11,798.50

10,760.90

7,902.10

7,310.50

5,485.80

Less : current liabilities & provisions

2,194.80

2,101.70

1,836.90

1,803.20

2,336.90

Total net current assets

9,603.70

8,659.20

6,065.20

5,507.30

3,148.90

Miscellaneous expenses not written

-

-

-

-

-

Total

21,890.00

18,461.90

15,903.10

16,660.40

14,214.60

Notes:

Book value of unquoted investments

5,726.60

3,106.60

3,307.30

5,143.20

5,098.90

Market value of quoted investments

5,732.20

6,020.50

5,859.60

7,320.70

4,835.00

Contingent liabilities

1,750.30

752.40

2,233.10

2,009.30

4,090.90

Number of equity sharesoutstanding (Lacs)

10062.34

10122.04

10237.43

10237.43

10237.43